Published in Transplantation on July 27, 2010
Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev (2014) 1.43
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant (2011) 1.28
Adenovirus disease in six small bowel, kidney and heart transplant recipients; pathology and clinical outcome. Virchows Arch (2015) 0.75
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med (2005) 4.27
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
The neutropenic diet reviewed: moving toward a safe food handling approach. Oncology (Williston Park) (2012) 2.14
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr (2012) 1.72
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics (2004) 1.60
Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation (2008) 1.57
Successful rehabilitation in pediatric ultrashort small bowel syndrome. J Pediatr (2013) 1.45
Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.44
Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl (2006) 1.41
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.39
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. Hepatology (2009) 1.38
Melanoma. J Natl Compr Canc Netw (2009) 1.37
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2008) 1.36
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2012) 1.35
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 1.23
A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg (2005) 1.18
Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med (2015) 1.18
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis (2005) 1.17
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology (2006) 1.13
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl (2010) 1.11
Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood (2003) 1.10
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
Melanoma, version 4.2014. J Natl Compr Canc Netw (2014) 1.07
Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One (2009) 1.05
Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg (2007) 1.05
Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care (2011) 1.04
Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr (2007) 1.03
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2008) 1.02
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system. J Clin Microbiol (2004) 1.02
Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol (2008) 1.00
Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. Pediatr Infect Dis J (2008) 0.99
Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol (2006) 0.98
MOP3, a component of the molecular clock, regulates the development of B cells. Immunology (2006) 0.98
Liver and intestine transplantation. Am J Transplant (2004) 0.97
Repeat surgical bowel lengthening with the STEP procedure. Transplantation (2008) 0.97
Antibacterial prophylaxis in patients with neutropenia. J Natl Compr Canc Netw (2007) 0.96
Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion. J Pediatr Gastroenterol Nutr (2013) 0.96
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Myeloid growth factors. J Natl Compr Canc Netw (2009) 0.94
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94
Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med (2013) 0.93
Mice with chimeric human livers: who says supermodels have to be tall? Hepatology (2005) 0.92
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation (2008) 0.92
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clin Infect Dis (2002) 0.92
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol (2005) 0.92
Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant (2011) 0.91
Gallbladder pathology in morbid obesity. Obes Surg (2005) 0.91
Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant (2008) 0.91
Portosystemic shunts in children: a 15-year experience. J Am Coll Surg (2004) 0.90
Melanoma. J Natl Compr Canc Netw (2012) 0.90
Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.90
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.89
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2012) 0.89
Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl (2006) 0.89
Current management of the short bowel syndrome. Surg Clin North Am (2011) 0.89
Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States. Crit Care Med (2015) 0.88
Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis. Crit Care (2013) 0.88
Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors. Clin Transplant (2009) 0.87
Current management of short bowel syndrome. Curr Probl Surg (2012) 0.87
Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant (2008) 0.87
Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol (2005) 0.87
Liver transplantation for hepatocellular carcinoma: an update. J Natl Compr Canc Netw (2006) 0.86
Quality of life after pediatric intestinal transplantation: the perception of pediatric recipients and their parents. Am J Transplant (2004) 0.85
No place like home? Outpatient management of patients with febrile neutropenia and low risk. J Clin Oncol (2011) 0.85
Short bowel syndrome following bariatric surgical procedures. Am J Surg (2006) 0.85
Short bowel syndrome and Crohn's disease. J Gastrointest Surg (2003) 0.85
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry. Mycoses (2014) 0.85
The "last breath" of the ventilator-associated pneumonia surveillance definition*. Crit Care Med (2014) 0.84
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2014) 0.84
Stool calprotectin monitoring after small intestine transplantation. Transplantation (2011) 0.83
Melanoma. J Natl Compr Canc Netw (2006) 0.83
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int (2007) 0.83
An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation. Transplantation (2014) 0.83
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia. Chest (2004) 0.83
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results? Crit Care Med (2011) 0.83